Daiichi Sankyo
Teresa Grover is an accomplished professional in contract management with extensive experience in various roles across multiple organizations. Currently serving as Associate Director of Site Contracts & Budget Management at Daiichi Sankyo, Inc. since December 2022, Grover has previously held senior positions including Senior Manager for Clinical Contracts at Loxo Oncology at Lilly, and Manager of Clinical Contracts and Vendor Strategy Management at Seagen. Teresa's expertise encompasses complex contract negotiations, workflow optimization, and team management, demonstrated through leadership roles managing large teams and multi-disciplinary projects. Academic qualifications include a Master of Public Administration from the University of Washington, and both a Bachelor of Arts in Political Science from the University of the Philippines and a Bachelor of Laws from Manuel L. Quezon University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.